Capricor Therapeutics, Inc. , a diversified heart failure biotechnology company, today announced that, effective today, the Company's common stock commences trading on the OTC Markets under the new symbol "CAPR."
http://technews.tmcnet.com/news/2013/12/20/7603525.htm
http://technews.tmcnet.com/news/2013/12/20/7603525.htm
No comments:
Post a Comment